Many studies have independently reported that ALDH1A-expressing cancers are more tumorigenic and predict worse clinical outcomes,12 while other studies show that ALDH1A1 and ALDH1A3 promote cardiovascular diseases or obesity.13 Here, ALDH1A3 is linked to cardiovascular disorder.